0001209191-18-053804.txt : 20181003
0001209191-18-053804.hdr.sgml : 20181003
20181003162527
ACCESSION NUMBER: 0001209191-18-053804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181001
FILED AS OF DATE: 20181003
DATE AS OF CHANGE: 20181003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARDON CHRISTIANA
CENTRAL INDEX KEY: 0001717679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 181105315
MAIL ADDRESS:
STREET 1: 86 SOUTH STREET
STREET 2: C/O SPRING BANK PHARMACEUTICALS, INC.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-01
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001717679
BARDON CHRISTIANA
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
1
0
1
0
Common Stock
2018-10-01
4
A
0
831
0.00
A
2296
D
Common Stock
833839
I
By UBS Oncology Impact Fund
Common Stock
54824
I
By Burrage Capital Healthcare Fund I, LP
Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to take shares in lieu of cash compensation for services as a director and committee member of the Issuer.
The Reporting Person's spouse is the Managing Member of MPM Oncology Impact Management GP LLC, an indirect General Partner of UBS Oncology Impact Fund L.P. ("Oncology Impact Fund"). Dr. Bardon disclaims beneficial ownership of the securities held by Oncology Impact Fund, except to the extent of her or her spouse's pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose.
The Reporting Person is the Portfolio Manager of Burrage Capital Healthcare Fund I, L.P. ("Burrage Capital"). Dr. Bardon disclaims beneficial ownership of the securities held by Burrage Capital, except to the extent of her pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose.
/s/ Christiana Bardon
2018-10-03